Optimal sampling strategies for early pharmacodynamic measures in tuberculosis

Journal of Antimicrobial Chemotherapy

Volumn 58, Issue 3, 2006, Pages 594-600

  Davies, G R ^a   Khoo, S H ^a   Aarons, L J ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Clinical trials; Optimal design; Phase II; Sample size; Tuberculosis

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; THIOACETAZONE; TUBERCULOSTATIC AGENT;

ACCURACY; ANALYTIC METHOD; ANALYTICAL ERROR; ARTICLE; BACTERIUM COLONY; CONTROLLED STUDY; DRUG DESIGN; DRUG EFFICACY; HUMAN; LUNG TUBERCULOSIS; METHODOLOGY; PROCESS MODEL; PROCESS OPTIMIZATION; PUBLISHING; SAMPLE SIZE; SENSITIVITY ANALYSIS; SPUTUM ANALYSIS; STATISTICAL MODEL; STATISTICAL PARAMETERS;

ANTITUBERCULAR AGENTS; COLONY COUNT, MICROBIAL; COMPUTER SIMULATION; HUMANS; MODELS, BIOLOGICAL; PREDICTIVE VALUE OF TESTS; SAMPLE SIZE; SPECIMEN HANDLING; SPUTUM; TUBERCULOSIS, PULMONARY;

EID: 33747891289     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl272     Document Type: Article

References (21)

1. Global Alliance for TB Drug Development. Scientific Blueprint for Tuberculosis Drug Development. GATBDD 2001.
2. Jindani A, Dore CJ, Mitchison DA. Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days. Am J Respir Crit Care Med 2003; 167: 1348-54.
3. Mitchison DA, Allen BW, Carrol L et al. A selective oleic acid albumin agar medium for tubercle bacilli. J Med Microbiol 1971; 5: 165-75.
4. Brindle RJ, Nunn PP, Githui W et al. Quantitative bacillary response to treatment in HIV-associated pulmonary tuberculosis. Am Rev Respir Dis 1993; 147: 958-61.
5. Davies GR, Brindle R, Khoo SH et al. Improved precision of early pharmacodynamic measures in tuberculosis using non-linear mixed effects analysis. Antimicrob Agents Chemother 2006, in press.
6. Jindani A, Aber VR, Edwards EA et al. The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am Rev Respir Dis 1980; 121: 939-49.
7. Sirgel FA, Donald PR, Odhiambo J et al. A multicentre study of the early bactericidal activity of anti-tuberculosis drugs. J Antimicrob Chemother 2000; 45: 859-70.
8. Brindle R, Odhiambo J, Mitchison D. Serial counts of Mycobacterium tuberculosis in sputum as surrogate markers of the sterilising activity of rifampicin and pyrazinamide in treating pulmonary tuberculosis. BMC Pulm Med 2001; 1: 2-9.
9. Kennedy N, Fox R, Kisyombe GM. Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis. Am Rev Resp Dis 1993; 148: 1547-51.
10. Joloba ML, Johnson JL, Namale A et al. Quantitative sputum bacillary load during rifampin-containing short course chemotherapy in human immunodeficiency virus-infected and non-infected adults with pulmonary tuberculosis. Int J Tuberc Lung Dis 2000; 4: 528-36.
11. Gosling RD, Uiso LO, Sam NE et al. The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis. Am J Respir Crit Care Med 2003; 168: 1342-5.
12. Davidian M, Giltinan DM. Non-Linear Models for Repeated Measurement Data. London: Chapman Hall, 1995.
13. Pinheiro JC, Bates DM. Mixed-Effects Models in S and S-Plus. New York: Springer Verlag, 2000.
14. Hsieh FY, Lavori PW, Cohen HJ et al. An overview of variance inflation factors for sample-size calculation. Eval Health Prof 2003; 26: 239-57.
15. Kang D, Schwartz JB, Verotta D. A sample size computation method for non-linear mixed effects model with applications to pharmacokinetics models. Stat Med 2004; 23: 2551-66.
16. Retout S, Mentre F and Bruno R. Fisher information matrix for non-linear mixed-effects models: Evaluation and application for optimal design of enoxaparin population pharmacokinetics. Stat Med 2002; 21: 2623-39.
17. R version 2.01, R Development Core Team. 2004. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, available at http://www.R-project.org.
18. Gillespie SH, Gosling RD, Charalambous BM. A reiterative method for calculating the early bactericidal activity of antituberculosis drugs. Am J Respir Crit Care Med 2002; 166: 31-5.
19. Dore CJ, Nunn AJ. Bactericidal activity of antituberculous drugs. Am J Respir Crit Care Med 2003; 167: 663.
20. Marquardt DW. Generalized inverses, ridge regression, biased linear estimation and nonlinear estimation. Technometrics 1970; 12: 591-612.
21. Seber CAF, Wild CJ. Nonlinear Regression. New Jersey: Wiley & sons, 2003.